Prevention and Innovation for a Healthier Tomorrow | Global Conference 2024

Macro-Context and Systemic Challenges

• The U.S. healthcare system consumes approximately 20% of GDP, yet outcomes remain misaligned with spend.
• Demographic shifts include declining birth rates in Western and Asian high-income economies versus rising birth rates in Sub-Saharan Africa.
• Life expectancy is rising, but later years often do not correlate with improved health, leading to a surge in chronic diseases.
• Chronic disease prevalence is driven by lifestyle factors, nutrition, and disparities in access to medical services.
• Cardiovascular disease, cancer, and other conditions continue to yield poor outcomes globally, necessitating new solution sets.
• Innovation is viewed as essential but insufficient without parallel innovation in implementation and distribution.
• AI is positioned as a tool to augment, not replace, the healthcare workforce to reduce physician administrative burden.
• A primary goal of AI integration is to increase physician-patient interaction time rather than add to clinical workload.

Medicare Strategy and Policy (Meena Seshomani, CMS)

• Medicare covers over 65 million individuals and processes nearly $1 trillion in annual claims, serving as a market signal for the broader system.
• The agency aims to shift from a "sick care" model to a holistic "health care" model by addressing social determinants of health.
• Over 50% of traditional Medicare enrollees are now enrolled in value-based care arrangements where providers share accountability for cost and quality.
• A specific case study noted a community health worker resolving a patient's repeated ER admissions (17 visits in 3 months) by fixing utility payment barriers for a COPD patient.
• The Inflation Reduction Act's provision for $0 out-of-pocket costs for preventive vaccines increased shingles vaccination uptake from 3 million to 10 million seniors.
• Medicare is instituting a "Universal Foundation" to align and simplify quality metrics across all programs.
• A $2,000 annual out-of-pocket cap for prescription drug costs for Medicare beneficiaries will take effect on January 1, 2025.
• CMS is negotiating prices for the first ten selected drugs under the Inflation Reduction Act, incorporating patient feedback via listening sessions.

Cancer Prevention and Care Delivery (Karen Knudsen, American Cancer Society)

• Over 2 million new cancer cases are expected in the U.S. in 2024, with cancer identified as the primary cost driver for self-insured employers.
• Only 42% of cancers are attributable to modifiable risk factors; the remaining majority require a strategy bundling prevention with early detection.
• Diagnosing cancer at Stage 1 versus Stage 4 results in a 75% difference in treatment costs.
• Early detection significantly improves survival, with patients being six to eight times more likely to survive cancer if caught early.
• Financial toxicity is a critical barrier, with 42% of U.S. cancer patients depleting their life savings upon diagnosis.
• The ACS advocates for the Multi-Cancer Early Detection (MCED) Act to establish federal reimbursement pathways for emerging screening technologies.
• If current innovations were fully implemented without further R&D, U.S. cancer mortality could be reduced by 20%.
• HPV vaccination is highlighted as a critical prevention tool; Puerto Rico aims to end cervical cancer with 90% adolescent vaccination rates.

Technology, Data, and Interoperability (David Feinberg, Oracle Health)

• The U.S. digitized medical records over a 40-year period, but true interoperability remains unachieved.
• Oracle Health is launching the "Oracle Digital Clinical Assistant," an AI-driven tool designed to summarize patient data and automate administrative tasks.
• Clinical discovery trials currently suffer from lack of diversity; Oracle's network includes over 100 million records with three times the diversity of national trials.
• The healthcare industry lacks a unified data platform comparable to the open, connected ecosystems found in banking, retail, and travel.
• Approximately 50% of nurse time is spent on terminals or searching for supplies, described as a "workforce allocation" rather than a "shortage" issue.
• Oracle plans to increase API accessibility to Electronic Health Records (EHRs) by 300% to encourage third-party innovation.
• The organization aims to eliminate the "Explanation of Benefits" (EOB) confusion by creating transparent, immediate payment processing similar to retail transactions.

Pharmaceutical Innovation and System Friction (Bob Bradway, Amgen)

• Approximately $600 billion in U.S. GDP is lost annually due to preventable heart disease and stroke events.
• The administrative complexity of the U.S. healthcare system consumes 18% of all healthcare spend, exceeding the 14% cost of all medicines combined.
• Administrative costs are estimated at over $800 billion annually, driven by fragmented billing, records, and antiquated systems.
• The system is criticized for rewarding the treatment of broken bodies rather than the prediction and prevention of disease.
• Amgen is focusing on breakthrough therapies for small cell lung cancer, obesity, and autoimmune disorders expected in the next 12–24 months.
• Innovation ecosystems in the U.S. are at risk and require protection to continue fostering biomedical advancement.

Forward-Looking Statements and Strategic Priorities

• Medicare: Prioritizes primary care, behavioral health integration, and the full implementation of the $2,000 drug cost cap.
• American Cancer Society: Will escalate funding for home-based screening (AHEAD Grants) and advocate for MCED reimbursement legislation.
• Oracle Health: Will build a full end-to-end platform rather than point solutions, emphasizing humility and open connectivity to prevent ecosystem fragmentation.
• Amgen: Focuses on ensuring patient access to new therapies and leveraging digital environments to remove friction between innovation and treatment.
• General Consensus: All panelists agree that the current system's complexity is "impoding" and that fundamental structural changes, rather than incremental "Band-Aids," are required.